Opportunity Information: Apply for CDC RFA GH11 11040502SUPP16
Apply for CDC RFA GH11 11040502SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement for Support the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Central Province in the Republic of Kenya by Engaging Local Indigenous Partners PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jul 29, 2016.
- Applicants must submit their applications by Sep 27, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,400,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, issued by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention (HHS/CDC) under PEPFAR, is a program expansion supplement focused on Central Province, Kenya. Its core aim is to keep building on HIV clinical services and antiretroviral treatment (ART) work that was previously started through a centrally funded CDC program, while deliberately shifting more implementation responsibility to local, indigenous Kenyan partners. In practical terms, the grant is meant to help Kenyan organizations continue what is already working in HIV prevention and treatment, expand coverage so more people can access services, and strengthen local systems so Kenyan institutions can increasingly lead and sustain HIV care and treatment programs over time. Although activities are expected to occur mainly in public-sector health facilities, the opportunity is not limited only to public facilities.
A central theme of the program is capacity building paired with service delivery. The FOA emphasizes both technical assistance (hands-on guidance, mentorship, systems strengthening, quality improvement, and program management support) and direct funding so local organizations can operate, scale, and improve comprehensive HIV services. The idea is not just to increase the volume of services, but to improve the quality and reliability of care across the full HIV continuum, from identifying people with HIV to linking them to care, initiating treatment, and supporting long-term retention and viral suppression. The cooperative agreement mechanism signals that CDC is expected to be substantially involved with the recipient through collaboration, technical input, and oversight rather than simply issuing a check and stepping back.
Programmatically, the opportunity covers a wide spectrum of HIV prevention, care, and treatment interventions. It explicitly includes prevention of mother-to-child transmission (PMTCT), reflecting a priority to reduce new pediatric infections by strengthening services for pregnant and breastfeeding women and ensuring early infant diagnosis and follow-up. It also includes TB/HIV testing and treatment, acknowledging that tuberculosis is a major cause of illness and death among people living with HIV and that integrated screening, diagnosis, and treatment are essential. The FOA supports pediatric and adult HIV care and pediatric and adult ART services, indicating attention to both clinical management and medication access and adherence support. Nutrition programming is included as well, which is often critical for treatment outcomes and overall health, particularly for vulnerable patients. Additional supported interventions include prevention with positives (PWP), which focuses on reducing onward transmission and improving health outcomes among people already living with HIV; post-exposure prophylaxis (PEP) for preventing infection after potential exposure; voluntary medical male circumcision (VMMC) as an evidence-based prevention strategy; behavior change interventions to reduce risk and improve uptake of services; and HIV counseling and testing, with a specific callout for provider-initiated testing and counseling (PITC), which is commonly implemented in clinical settings to identify undiagnosed infections and link patients to care.
Beyond the core HIV package, the FOA allows applicants to place some emphasis on related health priorities that affect patients receiving HIV services, as long as these additions support overall care. Examples listed include malaria; emerging and re-emerging infections; neglected tropical diseases; influenza and other diseases with pandemic potential; environmental health issues; chronic diseases; maternal and child health; reproductive health; public health preparedness; biosafety; and injury control and prevention. This flexibility reflects a recognition that HIV outcomes are shaped by broader health system factors and co-occurring conditions, and that integrating selected services can improve patient retention, reduce morbidity, and make clinic encounters more useful and patient-centered.
The opportunity aligns with PEPFAR and CDC country programming approaches under the leadership of the U.S. Global AIDS Coordinator. CDC describes its role as working with host countries and key partners to assess needs and design assistance that fits within the host nation strategic plan and partnership framework. In other words, applicants are expected to implement activities consistent with national priorities and coordinated planning, rather than running isolated projects. The FOA also notes that CDC typically concentrates on a limited number of major program areas in each country, which underscores the expectation of focused, high-impact programming rather than scattered activities.
The stated goals and priorities fall into four broad buckets. First is primary prevention of HIV infection, including expanding confidential counseling and testing linked to evidence-based behavior change and strengthening programs that reduce mother-to-child transmission. Second is improving care and treatment for HIV/AIDS, sexually transmitted infections, and opportunistic infections by strengthening STI management, improving laboratory diagnostic capacity, enhancing diagnosis and treatment of opportunistic infections, addressing intercurrent diseases like tuberculosis that strongly influence HIV outcomes, and initiating or expanding ART programs. Third is strengthening national and subnational capacity to collect, analyze, and use surveillance and program data, including expanding HIV/STI/TB surveillance systems and reinforcing laboratory support for surveillance, diagnosis, treatment, monitoring, and blood safety screening. Fourth is developing, validating, and evaluating public health programs so that interventions are better targeted and continuously improved, particularly in relation to HIV, TB, and opportunistic infections. Taken together, these priorities show that the grant is not only about clinic services, but also about the data and laboratory backbone that makes those services effective and accountable.
From an administrative standpoint, the opportunity is a discretionary cooperative agreement (CFDA 93.067) with an anticipated single award. The award ceiling listed is $1,400,000, and the timeline provided in the posting indicates it was created July 29, 2016, with an original closing date of September 27, 2016 (applications due electronically by 11:59 p.m. ET on the deadline). Eligibility is described broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the narrative focus on engaging local indigenous partners strongly suggests that Kenyan local organizations were a primary target for this supplement, especially those positioned to manage and deliver HIV care and treatment services in Central Province.
Overall, this FOA is best understood as a targeted investment meant to expand and improve high-quality HIV services in Central Province, while accelerating localization by strengthening Kenyan organizations to lead implementation. It combines prevention, testing, treatment, and supportive services with health systems strengthening in laboratories, surveillance, and program management, all within the PEPFAR framework and in coordination with Kenya's national strategies.
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This is a CDC (HHS/CDC) funding opportunity under PEPFAR designed as a program expansion supplement for HIV services in Central Province, Kenya. It builds on HIV clinical services and antiretroviral treatment (ART) work that was started under a centrally funded CDC program, with a deliberate shift toward greater implementation leadership by local, indigenous Kenyan partners.
What is the main goal of the program expansion supplement?
The core goal is to continue and expand effective HIV prevention and treatment services while strengthening local systems so Kenyan institutions can increasingly lead, manage, and sustain HIV care and treatment programs over time. The focus is on both expanding coverage and improving the quality and reliability of services across the HIV continuum.
Where are activities expected to take place?
Activities are expected to occur mainly in Central Province, Kenya, and primarily in public-sector health facilities. However, the opportunity is not limited only to public facilities.
What makes this a "cooperative agreement" rather than a standard grant?
The award is described as a discretionary cooperative agreement, which means CDC is expected to be substantially involved with the recipient through collaboration, technical input, and oversight. In practical terms, CDC is not simply providing funds and stepping back; the model emphasizes partnership and ongoing engagement.
What types of support does the FOA emphasize for local partners?
A central theme is capacity building paired with service delivery. The FOA emphasizes technical assistance (such as mentorship, systems strengthening, quality improvement, and program management support) alongside direct funding so local organizations can operate, scale, and improve comprehensive HIV services.
Which parts of the HIV care continuum are addressed?
The FOA emphasizes improving quality and reliability across the full HIV continuum, including identifying people with HIV, linking them to care, initiating treatment, and supporting long-term retention and viral suppression.
What HIV prevention and treatment interventions are explicitly included?
The program scope includes PMTCT (prevention of mother-to-child transmission), TB/HIV testing and treatment, pediatric and adult HIV care, pediatric and adult ART services, nutrition programming, prevention with positives (PWP), post-exposure prophylaxis (PEP), voluntary medical male circumcision (VMMC), behavior change interventions, and HIV counseling and testing including provider-initiated testing and counseling (PITC).
Does the opportunity include PMTCT and early infant services?
Yes. PMTCT is explicitly included, with an emphasis on strengthening services for pregnant and breastfeeding women, supporting early infant diagnosis, and ensuring follow-up.
How does the FOA address TB/HIV?
TB/HIV testing and treatment are explicitly included, reflecting the importance of integrated screening, diagnosis, and treatment because tuberculosis is a major cause of illness and death among people living with HIV.
Are both adults and children covered under the program?
Yes. The FOA supports both pediatric and adult HIV care and both pediatric and adult ART services.
Is nutrition part of the supported activities?
Yes. Nutrition programming is included, recognizing its importance for treatment outcomes and overall health, particularly for vulnerable patients.
Does the FOA support HIV testing approaches in clinical settings?
Yes. HIV counseling and testing are included, with a specific callout for provider-initiated testing and counseling (PITC), which is commonly implemented in clinical settings to identify undiagnosed infections and link patients to care.
Can applicants include services beyond HIV, TB, and STIs?
Yes, the FOA allows applicants to place some emphasis on related health priorities that affect patients receiving HIV services, as long as these additions support overall care.
What examples of additional health priorities are mentioned?
Examples listed include malaria; emerging and re-emerging infections; neglected tropical diseases; influenza and other diseases with pandemic potential; environmental health issues; chronic diseases; maternal and child health; reproductive health; public health preparedness; biosafety; and injury control and prevention.
Why does the FOA allow related health priorities beyond HIV?
The rationale described is that HIV outcomes are influenced by broader health system factors and co-occurring conditions. Integrating selected services can improve retention, reduce morbidity, and make clinic encounters more useful and patient-centered.
How does this opportunity align with PEPFAR country programming?
The FOA aligns with PEPFAR and CDC country programming approaches under the leadership of the U.S. Global AIDS Coordinator. CDC describes its role as working with host countries and key partners to assess needs and design assistance that fits within the host nation strategic plan and partnership framework.
Are applicants expected to coordinate with national strategies and plans?
Yes. The FOA emphasizes that activities should be consistent with national priorities and coordinated planning, rather than isolated projects, and should fit within the host nation strategic plan and partnership framework.
Is the program expected to be broad or focused?
The FOA notes that CDC typically concentrates on a limited number of major program areas in each country, pointing toward focused, high-impact programming rather than scattered activities.
What are the four broad goal areas described in the FOA?
The four goal areas are: (1) primary prevention of HIV infection; (2) improving care and treatment for HIV/AIDS, sexually transmitted infections, and opportunistic infections; (3) strengthening national and subnational capacity to collect, analyze, and use surveillance and program data (including laboratory support and blood safety screening); and (4) developing, validating, and evaluating public health programs to improve targeting and continuous improvement, particularly for HIV, TB, and opportunistic infections.
How does the FOA address laboratories and surveillance?
Laboratory and surveillance strengthening are included as priorities, including improving laboratory diagnostic capacity, reinforcing laboratory support for surveillance and monitoring, expanding HIV/STI/TB surveillance systems, and supporting screening related to blood safety.
Is this opportunity only about increasing service numbers?
No. The FOA emphasizes improving quality and reliability across services, alongside expanding coverage. It pairs service delivery with quality improvement, systems strengthening, and program management support.
What is the funding mechanism and assistance listing information provided?
The FOA is described as a discretionary cooperative agreement with CFDA number 93.067.
How many awards are anticipated?
The posting indicates an anticipated single award.
What is the award ceiling?
The award ceiling listed is $1,400,000.
What are the key dates included in the posting?
The timeline shown indicates the opportunity was created on July 29, 2016, with an original closing date of September 27, 2016. Applications were due electronically by 11:59 p.m. ET on the deadline.
Who is eligible to apply based on the information provided?
Eligibility is described broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)." The narrative emphasis on shifting implementation to local, indigenous Kenyan partners strongly suggests Kenyan local organizations positioned to manage and deliver HIV care and treatment services in Central Province were a primary target for this supplement.
Does the FOA require work only in public-sector facilities?
No. While activities are expected mainly in public-sector health facilities, the FOA states the opportunity is not limited only to public facilities.
What is meant by "localization" in this FOA?
Localization, as described, is the intentional shift of implementation responsibility toward local, indigenous Kenyan partners, paired with capacity building so Kenyan institutions can increasingly lead and sustain HIV care and treatment programs over time.
What is the overall takeaway from this FOA?
This FOA is a targeted investment to expand and improve high-quality HIV services in Central Province, Kenya, while accelerating local leadership. It combines prevention, testing, treatment, and supportive services with health systems strengthening in laboratories, surveillance, and program management, all within the PEPFAR framework and in coordination with Kenya's national strategies.
Browse more opportunities from the same category: Health
Next opportunity: BLM WY Youth Opportunities Wyoming Public Lands Conservation Projects
Previous opportunity: NOI TA: Cultural Landscape Preservation Planning Intern
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 11040502SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 11040502SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement for Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15440201SUPP16 Funding Number: CDC RFA GH15 15440201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $401,462 |
| Program Expansion Supplement: Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District-based Comprehensive Prevention, Care and Treatment Program and Health Systems Strengthening under PEPFAR Apply for CDC RFA GH15 15480201SUPP16 Funding Number: CDC RFA GH15 15480201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $388,800 |
| Program Expansion Supplement:Reducing New HIV Infections, Strengthening Health & Strategic Information Systems, Capacity Building & Increasing Access to Quality HIV/AIDS services through Support Programs Conducted by the Govt of Botswana under PEPFAR Apply for CDC RFA GH11 11970401SUPP16 Funding Number: CDC RFA GH11 11970401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $425,000 |
| Program Expansion Supplement: Supporting Health Worker Staffing in South Africa under PEPFAR Apply for CDC RFA GH11 11100501SUPP16 Funding Number: CDC RFA GH11 11100501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,360,545 |
| Program Expansion Supplement for District Health System Strengthening and Quality Improvement for Service Delivery in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12480401SUPP16 Funding Number: CDC RFA GH12 12480401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $310,982 |
| Program Expansion Supplement: Strengthening the SA National Department of Health to implement and evaluate evidence-based public health program, surveillance and disease control efforts under PEPFAR Apply for CDC RFA GH13 13370501SUPP16 Funding Number: CDC RFA GH13 13370501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $13,500,000 |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance to the NTCP in Swaziland under PEPFAR Apply for CDC RFA GH15 15830201SUPP16 Funding Number: CDC RFA GH15 15830201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $420,148 |
| Program Expansion Supplement: Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15810201SUPP16 Funding Number: CDC RFA GH15 15810201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,628,300 |
| Program Expansion Supplement: Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12500401SUPP16 Funding Number: CDC RFA GH12 12500401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520502SUPP16 Funding Number: CDC RFA GH11 11520502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $876,491 |
| Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15510201SUPP16 Funding Number: CDC RFA GH15 15510201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,345,600 |
| Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa Apply for CDC RFA GH11 11090501SUPP16 Funding Number: CDC RFA GH11 11090501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $15,000,000 |
| Program Expansion Supplement: Technical Assistance Services to Countries Supported by the President's Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 13680302SUPP16 Funding Number: CDC RFA GH13 13680302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| National Hemophilia Program Coordinating Center Apply for HRSA 17 087 Funding Number: HRSA 17 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improvement of Laboratory and Clinical Services, and Collaboration across the National HIV and TB Programs in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1711 Funding Number: CDC RFA GH17 1711 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Regional Hemophilia Network Apply for HRSA 17 074 Funding Number: HRSA 17 074 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Polio Eradication and Emergency Response in Priority Countries Apply for CDC RFA GH16 172102CONT17 Funding Number: CDC RFA GH16 172102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance in Swaziland Natl AIDS Program under PEPFAR Apply for CDC RFA GH15 15820201SUPP16 Funding Number: CDC RFA GH15 15820201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $355,549 |
| Cooperative Agreement on Immunization with United Nations Children's Fund (UNICEF) Apply for CDC RFA GH13 13020401SUPP16 Funding Number: CDC RFA GH13 13020401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in SA under PEPFAR Apply for CDC RFA GH11 11540501SUPP16 Funding Number: CDC RFA GH11 11540501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 11040502SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.